|
Bibliografía:
1.
Rojas-Serrano, J. Lupus patients in an emergency
unit. Causes of consultation,
hospitalization and outcome. A cohort study. Lupus;
2000;9:601-606.
2.
Cervera R, et al. Morbidity and mortality in systemic
lupus erythematosus during a 10-year period: a
comparison of early and late manifestations in a cohort
of 1,000 patients.
Medicine
(Baltimore) 2003;82(5):299-308.
3.
Rodríguez Garcia A, et al. Lupus Eritematoso Sistémico.
Etiología, Patogenia, Manifestaciones Clínicas y
Alteraciones de Laboratorio. Medicine
2000;8(29):1491-1504.
4.
Dobois EL. The clinical picture of systemic lupus
erythematosus. En: Kelly WN, Harris ED, Rudy S. Textbook
of Rheumatology. (2da ed). Second printing. Press,1979;
232-347.
5.
Petri M. Infections in systemic lupus
erithematosus. Rheum Dis Clin North Am 1998;24:423.
6.
Iliopoulos AG, Tsokos CG. Immunopathogenesis and
spectrum of infections in systemic lupus erithematosus.
Semin Arthritis Rheum 1996;23:318.
7.
De Luis A, et al.
Infections in 96 cases of systemic lupus erythematosus.
Med Clin (Barc) 1990;95(1):24.
8.
Aragon
Lara S. Fiebre en Lupus Eritematoso Generalizado:
Análisis de una Cohorte. Tesis de Posgrado 1998.
9.
Stahl NI, et al. Fever in systemic lupus
erythematosus.
Am J Med 1979;67(6):935-40.
10.
Inoue T,et al.
Differential diagnosis of fever in systemic lupus
erythematosus using discriminant analysis.
Rheumatol Int 1986;6(2):69-77.
11.
Rovin BH, Tang Y, Sun J, et al.
Clinical significance of fever in the systemic lupus
erythematosus patient receiving steroid therapy.
Kidney Int 2005;68:747-59.
12.
Borg EJ, et al. C-reactive protein levels during
disease exacerbations and infections in systemic lupus
erythematosus: a prospective longitudinal study.
J
Rheumatol 1990;17:1642-1648.
13.
Brunkhorst E.M, et al.
Procalcitonin for early diagnosis and differentation of
SIRS, sepsis, severe sepsis, and septic shock. Intensive
Care Med 2000;26:S148-S152.
14.
Cheval C, et al. Procalcitonin (pct) is useful in
predicting the bacterial origin of an acute circulatrory
failure in critically ill patients. Intensive Care Med
2000;26:S153-S158.
15.
Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM,
Brunkhorst R. Usefulness of procalcitonin for
differentiation between activity of systemic autoimmune
disease (systemic lupus erythematosus / systemic
antineutrophil cytoplasmic antibody-associated
vasculitis) and invasive bacterial infection. Arthritis
Rheum 1997; 40: 1250-1256. |
